Sichenzia Ross Friedman Ference LLP Advises Ladenburg Thalmann & Co. Inc. on $1 Million Secondary Public Offering for Arca Biopharma, Inc.
NEW YORK, August 2, 2012 (GLOBE NEWSWIRE) — New York- based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Ladenburg Thalmann & Co. Inc., as sole Placement Agent in a $1 million secondary public offering for Arca Biopharma, Inc. (“ARCA” NASDAQ). The registered direct offering was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,436,599 shares of common stock at an offering price of $0.391 per share and warrants to purchase 1,827,449 shares of common stock. The Sichenzia Ross team was led by partners Gregory Sichenzia and Marcelle Balcombe and associate Jeff Cahlon.
- Marc J. Ross, Esq. Presents a Legal Webinar Explaining the Confusion Surrounding Marijuana Law - May 27, 2020
- Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $75 Million At-The-Market Offering - May 26, 2020
- Sichenzia Ross Ference Founding Partner Marc J. Ross, Esq.to Present Legal Webinar on Federal Regulation Governing Marijuana-Related Businesses - May 26, 2020